SCHEMBL24065741

SCHEMBL24065741

N#Cc1ccc(-c2ccc(-c3ccc(-c4nc(-c5ccccc5)c5ccccc5n4)c4ccccc34)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
ATM Q13315 2/20 0.50
ABCG2 Q9UNQ0 5/20 0.49
ADORA2A P29274 2/20 0.47
ABCB1 P08183 1/20 0.42
NUDT1 P36639 2/20 0.42
KDM1A O60341 1/20 0.42
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 2/20 0.41
CLK4 Q9HAZ1 2/20 0.41
LMNA P02545 2/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPK1 P28482 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
SLC22A12 Q96S37 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065766 1.00 MEN1 (0.50) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL22652797 0.95 MEN1 (0.57) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL22652752 0.95 MEN1 (0.57) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL24065822 0.95 MEN1 (0.57) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL24065761 0.95 MEN1 (0.57) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL24065826 0.93 MEN1 (0.56) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL24065727 0.93 MEN1 (0.56) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL22652762 0.93 MEN1 (0.58) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL24065796 0.92 ADORA2A (0.43) MEN1KMT2AATMABCG2ADORA2A
SCHEMBL24065725 0.92 ADORA2A (0.43) MEN1KMT2AATMABCG2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC4, CRY1, TRPC1 MEN1 780/4885KMT2A 2776/4885ATM 4195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.